FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> FDA | Transparency

FDA draws back the veil

The transparency-minded FDA of Margaret Hamburg has taken the first step in its see-through makeover: the regulator has unveiled an Internet-based curriculum called "FDA Basics," aimed at helping site visitors understand what it does.

The Basics content--geared to the regulator's largest constituency, the American public--represents the first of three transparency phases; it's not until phase 3 that the regulator addresses its industry constituents.

The Basics curriculum resulted from recommendations made to the commissioner by a transparency task force, convened by her shortly after she became the 21st FDA commissioner last May. In the second phase of the initiative, the task force will make recommendations regarding public transparency of agency activities, with an eye toward protecting confidential information. Phase III, as mentioned, involves task force recommendations to the commissioner on FDA transparency to the industries it regulates.

- here's the FDA announcement
- see the FDA Basics content

Related Articles:
FDA boosts transparency to 77%
FDA reform advocates want trial, data transparency
FDA blog aims to chronicle transparency push


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:
Be the first to comment
More stories about FDA   Transparency  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.